PSP Research’s Tyra Biosciences TYRA Stock Holding History

PSP Research’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,000	Closed	-$613K	–	88
2026 Q1	$613K	Sell	16,000 -5,853	-27%	-$189K	0.43%	5
2025 Q4	$575K	Buy	+21,853	New	+$401K	0.5%	4

Other funds holding TYRA

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

APMC

Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

PSP Research's TYRA Position: Q2 2026 in Review

PSP Research sold out of Tyra Biosciences (TYRA) in Q2 2026, closing a stake of 16,000 shares — an estimated $613K sold.

PSP Research first reported a position in TYRA in Q4 2025 and held it in 2 quarters. The position peaked at $613K in Q1 2026. 170 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

PSP Research reported no remaining Tyra Biosciences position as of Q2 2026 after selling out during the quarter.
PSP Research sold 16,000 Tyra Biosciences shares in Q2 2026, an estimated $613K.
PSP Research first reported a position in Tyra Biosciences in Q4 2025 and held it in 2 quarters.
PSP Research's Tyra Biosciences position peaked at $613K in Q1 2026.
170 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on PSP Research's 13F filing for Q2 2026, filed 9 Jul 2026.